Press Release, 4th of February 2025
MITEM PHARMA acquires FLISINT® from SANOFI
Press Release, 25th of September 2024
MITEM PHARMA acquires worldwide rights to DESFERAL® (deferoxamine) with the backing of TECHLIFE CAPITAL and MACSF.